Craft

Advanced
ResTORbio

ResTORbio

Stock Price

$16

2020-09-18

Market Capitalization

$11.9 M

2020-09-18

ResTORbio Summary

Company Summary

Overview
ResTORbio is a company, developing medicines to treat aging-related diseases and conditions. It is focused on developing medicines that address conditions caused by immunosenescence, the decline in immune function due to aging. The company merged with Adicet Bio. 
Type
Public
Status
Closed
Founded
2016
HQ
Boston, MA, US | view all locations
Website
https://www.restorbio.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Chen Schor

    Chen Schor, Co-Founder, President and CEO

    • Joan Mannick

      Joan Mannick, Co-Founder, Chief Medical Officer

      • Frederick G. Hayden, Clinical Advisory Board Member

        • Lloyd Klickstein

          Lloyd Klickstein, Chief Scientific Officer

          LocationsView all

          1 location detected

          • Boston, MA HQ

            United States

            500 Boylston St 13th Floor

          ResTORbio Financials

          Summary Financials

          Net income (Q3, 2022)
          ($22.0M)
          EBIT (Q3, 2022)
          ($23.0M)

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX